Homeโ€บBiologyโ€บCell Biologyโ€บCell Communication
๐Ÿ”ฌ Full Lesson ยท Cell Biology
Reception ยท Transduction ยท Response
Cell Communication

Every hormone signal, nerve impulse, immune response, and cancer is fundamentally about cell communication. Cells constantly send and receive molecular messages โ€” and how they do it is the foundation of modern pharmacology and targeted cancer therapy.

The Framework
Three stages โ€” Reception, Transduction, Response

All cell signaling follows the same three-stage framework, regardless of the specific molecules involved. Understanding this framework explains how every hormone, drug, and signaling molecule works.

R
Reception โ€” the signaling molecule binds its receptor
A signaling molecule (ligand โ€” hormone, neurotransmitter, growth factor, cytokine) binds to a specific receptor. Receptor binding is highly specific โ€” like a lock and key โ€” and extraordinarily sensitive (nanomolar to picomolar concentrations are sufficient).

Location of the receptor depends on whether the ligand can cross the membrane: Lipid-soluble signals (steroid hormones, thyroid hormone, nitric oxide) โ†’ cross the membrane โ†’ bind intracellular receptors (cytoplasm or nucleus). Water-soluble signals (peptide hormones, neurotransmitters, growth factors) โ†’ cannot cross โ†’ bind surface receptors.
Memory trick: Reception = the cell answers the phone. The receptor is the phone. Only the right caller gets through.
T
Transduction โ€” the signal is amplified through a cascade
Signal transduction converts the extracellular signal into an intracellular message. Almost always involves a cascade of molecular switches that amplify the signal: one ligand binding one receptor โ†’ dozens of G-proteins activated โ†’ hundreds of cAMP molecules โ†’ thousands of PKA phosphorylations โ†’ millions of molecular events. This amplification is why tiny hormone concentrations produce massive cellular responses.
Memory trick: Transduction = turning up the volume. One signal in โ†’ millions of effects out. The cascade is the amplifier.
Res
Response โ€” the cell changes behavior
The response depends entirely on the cell type and pathway activated. Possible responses: changes in gene transcription, enzyme activation or inhibition, ion channel opening or closing, cytoskeletal rearrangement, secretion, cell division, or apoptosis. The same ligand produces different responses in different cell types: norepinephrine causes heart to beat faster (ฮฒ1 receptors), blood vessels to constrict (ฮฑ1 receptors), and bronchi to dilate (ฮฒ2 receptors). The receptor type determines the response.
Major Pathways
GPCRs and receptor tyrosine kinases โ€” the two dominant receptor families

Two receptor superfamilies account for the majority of cell signaling โ€” and both are major drug targets.

๐Ÿ’ก Types of Signaling by Distance
Cells communicate over different distances using different mechanisms:

Endocrine: hormones travel through bloodstream to distant targets (insulin from pancreas โ†’ muscle/fat throughout body).
Paracrine: local signals act on nearby cells (growth factors, inflammatory cytokines, nitric oxide).
Autocrine: cells signal themselves (cancer cells often overproduce their own growth factors โ†’ drive their own uncontrolled proliferation).
Synaptic: neurotransmitters released into synapse act on the immediate postsynaptic cell. Fast, precise, local.
Contact-dependent: requires direct cell-cell contact (Notch-Delta signaling in development, gap junctions for ion passage).
GPCR
G-protein coupled receptors โ€” the largest receptor family
GPCRs span the membrane seven times (7-TM receptors) and couple to heterotrimeric G-proteins. When a ligand binds: GPCR changes conformation โ†’ activates G-protein (GDPโ†’GTP on Gฮฑ) โ†’ Gฮฑ activates or inhibits effector enzymes.

Gs pathway: Gฮฑ-s โ†’ adenylyl cyclase โ†’ ATP โ†’ cAMP โ†’ PKA (protein kinase A) โ†’ phosphorylates target proteins โ†’ response. cAMP is degraded by phosphodiesterase (PDE). Caffeine inhibits PDE โ†’ prolonged cAMP โ†’ stimulant effect.

Gq pathway: Gฮฑ-q โ†’ phospholipase C โ†’ cleaves PIPโ‚‚ โ†’ IPโ‚ƒ + DAG. IPโ‚ƒ releases Caยฒโบ from ER. DAG activates PKC. Caยฒโบ and PKC are second messengers that activate downstream targets.

GPCR ligands include: epinephrine, glucagon, histamine, dopamine, serotonin, adenosine, acetylcholine (muscarinic), opioids, odorants, light (rhodopsin in photoreceptors). ~30% of all drugs target GPCRs.
Memory trick: GPCR โ†’ G-protein โ†’ adenylyl cyclase โ†’ cAMP โ†’ PKA โ†’ phosphorylation โ†’ response. OR Gq โ†’ PLC โ†’ IPโ‚ƒ + DAG โ†’ Caยฒโบ + PKC.
RTK
Receptor tyrosine kinases โ€” growth factor receptors
RTKs are single-pass transmembrane receptors with an intracellular kinase domain. When a growth factor binds: two RTK monomers dimerize โ†’ each phosphorylates the other on tyrosine residues (autophosphorylation) โ†’ phosphotyrosines become docking sites for adapter proteins โ†’ downstream cascades.

Ras-MAPK pathway: Ras GTPase โ†’ Raf โ†’ MEK โ†’ MAPK (ERK) โ†’ transcription factors โ†’ cell proliferation. Ras mutations that prevent GTP hydrolysis (permanently active) โ†’ uncontrolled growth โ†’ cancer in ~30% of human tumors (KRAS in pancreatic cancer, NRAS in melanoma).

PI3K-Akt pathway: PI3K โ†’ PIPโ‚ƒ โ†’ Akt โ†’ mTOR โ†’ cell survival and growth. PTEN (reverses PI3K) is a tumor suppressor lost in many cancers.

RTK examples: EGFR (targeted by erlotinib), HER2 (targeted by trastuzumab/Herceptin for HER2+ breast cancer), BCR-ABL fusion (targeted by imatinib/Gleevec for CML).
Memory trick: RTK = growth factor binds โ†’ dimerize โ†’ autophosphorylate โ†’ Ras โ†’ MAPK โ†’ grow and divide. Ras stuck 'on' = the most common cancer mutation mechanism.
๐Ÿ”ฌ Clinical Scenario โ€” Signaling in Drug Targets and Cancer
Cell signaling pathways are the molecular basis of how most drugs work and why cancers grow:
A
Beta-blockers and GPCRs. Epinephrine โ†’ ฮฒ1-adrenergic GPCR on cardiac cells โ†’ Gs โ†’ adenylyl cyclase โ†’ cAMP โ†’ PKA โ†’ faster/stronger contractions. Beta-blockers (metoprolol, atenolol) competitively block ฮฒ1 receptors โ†’ less cAMP โ†’ slower heart rate and reduced contractility โ†’ used for hypertension, heart failure, arrhythmia, post-MI protection. One of the most prescribed drug classes in the world โ€” all targeting GPCRs.
B
Imatinib (Gleevec) โ€” the paradigm of targeted therapy. In CML, the BCR-ABL fusion protein (from t(9;22) translocation) is a constitutively active tyrosine kinase permanently driving proliferation. Imatinib fits precisely into the ATP-binding site of BCR-ABL โ†’ blocks kinase activity โ†’ CML cells cannot proliferate โ†’ dramatic remissions in >90% of patients. First targeted cancer drug โ€” proved that understanding a signaling pathway leads to curative therapy.
C
KRAS in pancreatic cancer. KRAS mutation locks Ras in the GTP-bound (active) state permanently โ†’ continuous MAPK โ†’ uncontrolled proliferation โ†’ cancer. Found in ~95% of pancreatic cancers. KRAS was considered 'undruggable' for decades. KRAS G12C inhibitors (sotorasib, adagrasib) were recently approved for KRAS G12C-mutant lung cancer โ€” the first direct KRAS inhibitors.
D
Statins and intracellular signaling. Low cholesterol โ†’ SREBP transcription factor activated โ†’ upregulates HMG-CoA reductase โ†’ more cholesterol synthesized. Statins competitively inhibit HMG-CoA reductase โ†’ less intracellular cholesterol โ†’ SREBP stays active โ†’ but also upregulates LDL receptor โ†’ more LDL taken up from blood โ†’ lower LDL โ†’ reduced cardiovascular risk. One drug affecting two signaling responses simultaneously.
๐Ÿ“Œ Exam Application
Cell signaling is heavily tested in biology and pharmacology:

1. Three stages: Reception, Transduction (with amplification), Response.

2. GPCR pathway: ligand โ†’ GPCR โ†’ G-protein (GDPโ†’GTP) โ†’ adenylyl cyclase โ†’ cAMP โ†’ PKA โ†’ phosphorylation. OR Gq โ†’ PLC โ†’ IPโ‚ƒ + DAG โ†’ Caยฒโบ + PKC.

3. RTK pathway: growth factor โ†’ dimerization โ†’ autophosphorylation โ†’ Ras โ†’ MAPK โ†’ proliferation. Ras stuck 'on' = cancer in ~30% of tumors.

4. Steroid vs peptide hormones: Steroids = intracellular receptors (lipid-soluble, cross membrane). Peptides = surface receptors (water-soluble, cannot cross).

5. Drug targets: Beta-blockers = block ฮฒ1 GPCRs. Imatinib = blocks BCR-ABL RTK. Statins = block HMG-CoA reductase.
โš ๏ธ The Most Commonly Missed Signaling Concepts
Steroid hormones do NOT bind surface receptors. This is the most frequently missed signaling question. Steroid hormones (cortisol, aldosterone, testosterone, estrogen, progesterone, vitamin D) are lipid-soluble โ†’ cross the membrane โ†’ bind nuclear receptors โ†’ change gene expression. Peptide hormones (insulin, glucagon, GH, TSH, FSH, LH, ADH, oxytocin) are water-soluble โ†’ cannot cross โ†’ surface receptors โ†’ second messengers.

Signal amplification is the purpose of cascades. Each step amplifies: one hormone โ†’ dozens of G-proteins โ†’ hundreds of cAMP โ†’ thousands of PKA phosphorylations. This is why nanomolar hormone concentrations produce massive cellular responses.

Ras in RTK pathways is NOT the same as G-proteins in GPCR pathways. Both are GTPases (active when GTP-bound, inactive when GDP-bound), but Ras is a monomeric GTPase in the Ras-MAPK pathway. The Gฮฑ subunit is a heterotrimeric G-protein in the GPCR pathway. Different proteins, different pathways, both tested.
โœ“ Quick Self-Test
1. What are the three stages of cell signaling?
2. Why do steroid hormones have intracellular receptors while peptide hormones have surface receptors?
3. Describe the GPCR โ†’ cAMP โ†’ PKA pathway step by step.
4. What happens when Ras is mutated to be permanently active?
5. What is the difference between endocrine, paracrine, and autocrine signaling?

Answers:
1. Reception (signaling molecule binds receptor), Transduction (signal converted and amplified via intracellular cascade), Response (cell changes behavior โ€” gene expression, enzyme activity, secretion, division, apoptosis, etc.).
2. Steroid hormones are lipid-soluble โ†’ dissolve in and cross the plasma membrane โ†’ bind receptors inside the cell (cytoplasm or nucleus) โ†’ change gene expression. Peptide hormones are water-soluble โ†’ cannot cross the hydrophobic bilayer โ†’ bind receptors on the outer cell surface โ†’ trigger second-messenger cascades.
3. Ligand binds GPCR โ†’ conformational change activates G-protein (GDP replaced by GTP on Gฮฑ-s) โ†’ Gฮฑ-s activates adenylyl cyclase โ†’ ATP converted to cAMP โ†’ cAMP activates PKA โ†’ PKA phosphorylates target proteins โ†’ cellular response. Signal terminated when cAMP degraded by phosphodiesterase.
4. Mutant Ras cannot hydrolyze GTP to GDP โ†’ stays permanently in the active GTP-bound state โ†’ continuously signals through the MAPK pathway โ†’ persistent proliferation stimulus โ†’ uncontrolled cell division โ†’ cancer. Found in ~30% of all human cancers.
5. Endocrine: hormones secreted into blood and travel to distant targets (long-range). Paracrine: signals act locally on nearby cells. Autocrine: cells secrete signals that bind their own receptors (cancer cells often exploit this to drive their own growth).
Next Lesson
Cell Cycle Control
โ†’
 โ† All Cell Biology Lessons